Table 3 Baseline characteristics of studies in resistant P. aeruginosa
Author | Year | Design | Country | Case/Exposure | Control/Comparator | Total N | Age cases (Yr) | Age control (Yr) | Male cases (%) | Male controls (%) |
|---|---|---|---|---|---|---|---|---|---|---|
Akhabue [41] | 2011 | CC, unmatched | USA | Cefepime-resistant P.aeruginosa | Cefepime-susceptible P.aeruginosa | 2529 | Median:61 (total) | Median:61 (total) | 62 | 56.4 |
Fortaleza (b) [45] | 2006 | CC, matched | Brazil | Ceftazidime-resistant P.aeruginosa | Control | 165 | median 38 | median 44.5 | 72.7 | 62.7 |
Gasink [48] | 2006 | CC, unmatched | USA | Fluoroquinolone-resistant P.aeruginosa | Fluoroquinolone-susceptible P.aeruginosa | 847 | 56 | 62 | NR | NR |
Harris [49] | 2002 | CC, unmatched | USA | Piperacillin-tazobactam-resistant P. aeruginosa | Patients without Piperacillin-tazobactam-resistant P. aeruginosa | 1315 | 53.4 | 49.7 | 42.5 | 39.4 |
Hsu [52] | 2005 | CC, unmatched | USA | Fluoroquinolone-resistant P.aeruginosa | Fluoroquinolone-susceptible P.aeruginosa | 177 | 73.8 | 68 | 43 | 49 |
Khayr [53] | 2000 | CC, unmatched | USA | Ciprofloxacin-resistant P.aeruginosa | Ciprofloxacin-susceptible P.aeruginosa | 94 | Age > 65: 79% | Age > 65: 79% | 100 | 100 |
Trouillet [63] | 2002 | CC, unmatched | France | Piperacillin-resistant P. aeruginosa | Piperacillin-susceptible P. aeruginosa | 135 | 64.6 | 65.5 | 67.6 | 64.4 |